Surgical sponge market seen reaching $3.3 billion by 2030

The surgical sponge market is projected to grow from $2.64 billion in 2026 to $3.3 billion by 2030, according to The Business Research Company. Demand is rising as surgery volumes increase, hospitals modernize, and disposable and infection-control products gain traction.

Why it matters: - Surgical sponges are core operating-room supplies used to absorb blood and fluids, maintain visibility, and help reduce contamination risk. - Market growth points to more surgical volume, more disposable medical supply demand, and continued investment in healthcare infrastructure. - The category is also tied to patient safety and infection-control practices, which remain a priority across surgical care.

What happened: - The Business Research Company said the surgical sponge market was valued at $2.48 billion in 2025. - The market is projected to reach $2.64 billion in 2026. - The report forecasts the market will climb to $3.3 billion by 2030. - That implies a 5.8% CAGR over the 2026-2030 period. - North America was the largest regional market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Surgical sponges are typically made from gauze or other absorbent materials. - Their job is to keep the surgical field clean and visible during procedures. - The market’s historical growth reflects higher surgical volumes, hospital expansion, stricter infection-control protocols, trauma care demand and operating-room modernization. - Future growth is expected to come from minimally invasive surgeries, outpatient procedures, stronger patient-safety focus, more disposable medical supplies and broader healthcare infrastructure development. - Emerging product trends include X-ray detectable sponges, antimicrobial sponges, disposable surgical items and more standardized surgical kits. - The report cites a May 2025 Australian Institute of Health and Welfare update showing 778,500 patients were admitted for surgery from public hospital elective surgery waiting lists in 2023-24, up 5.8% from the prior year. - The Business Research Company said the new 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The company offered a free sample of the report at the market report sample. - The company also linked to the full market report.

Between the lines: - The forecast suggests surgical sponge demand is less about one product cycle and more about the steady expansion of procedures worldwide. - Preference is shifting toward products that improve safety, reduce handling risk and fit standardized surgical workflows. - The regional snapshot suggests mature markets still anchor demand while surgery growth in other regions could reshape the market mix over time.

What's next: - The market is expected to keep expanding through 2030 as hospitals continue modernizing and surgical volumes rise. - Adoption of minimally invasive and outpatient procedures should keep influencing sponge specifications and procurement choices. - Manufacturers are likely to focus on detectable, antimicrobial and disposable formats as buyers prioritize safety and efficiency.

The bottom line: - Surgical sponges remain a small but essential part of surgical care, and the market’s growth path tracks broader pressure on health systems to do more procedures with tighter safety controls.